EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Exogenous Insulin Antibody Syndrome: A Rare Cause of Extreme Insulin Resistance Treated With High-dose Corticosteroids

Hari Haran Rajamohan iD, Pierre-Nicolas Boyer iD, Timothy Davis, Michael Lane, Amanda Love

JCEM Case Reports · 19.08.2025 · 3 (10)

DOI: 10.1210/jcemcr/luaf175 ↗

Kurz gefasst

Fallbericht in der Zeitschrift JCEM Case Reports, online erschienen am 22.08.2025. Verfasst von Hari Haran Rajamohan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exogenous insulin antibody syndrome is a rare condition characterized by extreme insulin resistance caused by antibodies that neutralize the action of insulin. An 80-year-old woman with type 1 diabetes mellitus was transferred to an Australian quaternary hospital with refractory hyperglycemia and diabetic ketoacidosis despite receiving >300 units of insulin daily. Laboratory testing revealed a very high insulin antibody titer of 6758 U/mL (6758 kU/L)(<0.4 U/mL; <0.4 kU/L). Plasmapheresis was considered but was not pursued because of hemodynamic instability, multiple comorbidities and frailty. Treatment with high-dose methylprednisolone at 1 mg/kg for 5 days and 500 mg of mycophenolate mofetil twice daily, followed by a tapering regimen of prednisone, resulted in a significant improvement in extreme insulin resistance. The total daily dose of insulin after treatment returned to a baseline of approximately 70 units and insulin antibody titers were reduced by 8-fold. Remission was maintained for more than 2 years until the patient died of an aggressive squamous cell carcinoma of the buccal mucosa.

Schlagwörter

Stichwörter der Autor:innen

corticosteroidsexogenous insulin antibody syndromeextreme insulin resistancetype 1 diabetes mellitus

Autor:innen und Institutionen

  • Department of Endocrinology, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.
  • Royal Brisbane Clinical Unit, Faculty of Health, Medicine and Behavioural Sciences, University of Queensland, Brisbane, QLD 4006, Australia.
  • Department of Immunology, Royal Brisbane and Women's Hospital, Brisbane, QLD 4006, Australia.

ORCID-Profile: Hari Haran Rajamohan, Pierre-Nicolas Boyer

Zitieren

APA

Rajamohan, H. H., Boyer, P. N., Davis, T., Lane, M., & Love, A. (2025). Exogenous Insulin Antibody Syndrome: A Rare Cause of Extreme Insulin Resistance Treated With High-dose Corticosteroids. JCEM Case Reports, 3(10). https://doi.org/10.1210/jcemcr/luaf175

Vancouver

Rajamohan HH, Boyer PN, Davis T, Lane M, Love A. Exogenous Insulin Antibody Syndrome: A Rare Cause of Extreme Insulin Resistance Treated With High-dose Corticosteroids. JCEM Case Reports. 2025;3(10). doi:10.1210/jcemcr/luaf175

BibTeX
@article{Rajamohan2025,
  author = {Rajamohan, Hari Haran and Boyer, Pierre-Nicolas and Davis, Timothy and Lane, Michael and Love, Amanda},
  title = {Exogenous Insulin Antibody Syndrome: A Rare Cause of Extreme Insulin Resistance Treated With High-dose Corticosteroids},
  journal = {JCEM Case Reports},
  year = {2025},
  volume = {3},
  number = {10},
  doi = {10.1210/jcemcr/luaf175}
}
Kostenlos starten →